Simultaneous Detection of Colorectal Cancer Mutations in Stool Samples with Biochip Arrays

Abstract

Simultaneous Detection of Colorectal Cancer Mutations in Stool Samples with Biochip ArraysColorectal cancer (CRC) is the second main cause of cancer-related death in the Western world and like many other tumours is curable if detected at an early stage. Current detection options include faecal occult blood testing and invasive direct visualisation techniques such as flexible sigmoidoscopy, colonoscopy and barium enema. The availability of a more simple, non-invasive test that detects tumour specific products with optimal analytical performance might overcome barriers among patients who are not willing to undergo more sensitive but invasive tests. One such emerging technology, which has shown promise in recent years, is the analysis of DNA alterations exfoliated from tumour cells into stool. Here we report an analytical platform for non-invasive detection of 28 common mutations within CRC-related genesAPC, TP53, K-rasandBRAFin stool samples based on biochip array technology and applied to the semi-automated Evidence Investigator analyser. Mutation detection was possible in 1000-fold excess of wildtype DNA and analysis of 10 CRC-positive patient samples showed presence of targeted mutations with equivalent mutations also identified by an alternative method. This application represents an excellent tool for the multiplex detection of CRC-specific mutations using a single platform.

Study regarding drugs in blood with ELISA and chemiluminiscence versus ELISA with spectrophotometric detection

“…Biochips are sets of miniaturized test sites arranges in a solid substrate in which are included a large number of biomolecules, allowing the simultaneous detection of hundreds or even thousands molecules in a few seconds. Nowadays BAT is increasingly used in nanotoxicology and molecular pathology, including coronary and myocardial diseases [9][10][11], the responsiveness of various molecules to biologic and nonbiologic treatments [12,13], detection of adhesion molecules in the peripheral blood, detection of genetic mutations in colo-rectal cancer [14], the profile of ßamiloid peptides in CSF in Alzheimer patients [15], etc.…”